Genentech, Inc. - Company & Market Research Reports

Home /
Companies /
Genentech, Inc.

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 117
Immune Disorders Drugs 49
Central Nervous System Drugs 37
Biopharmaceuticals 37
Drug Discovery 33
Genomics 33
Optical Disorders Drugs 28
Optical 27
Pharmaceuticals 26
Respiratory Drugs 25
Biotechnology 23
Hematological Drugs 23
Clinical Trials 22
Endocrine and Metabolic Disorders Drugs 22
Cardiovascular Drugs 19
Women's Health 18
Breast Cancer Drugs 18
Infusions and Injectables 18
Lung Cancer Drugs 17
Musculoskeletal Disorders Drugs 17
Infectious Diseases Drugs 15
Oncology 15
Allergy and Immunology 14
Biosimilars and Biosuperiors 14
Liver and Kidney Disorders Drugs 13
Pulmonary Medicine 12
Leukemia Drugs 12
Lymphoma Drugs 12
Colon Cancer Drugs 12
Enzymes 12
Skin Cancer Drugs 12
Pharmaceutical Manufacturing 11
Ovarian Cancer Drugs 10
Cervical Cancer Drugs 10
Diagnostics 10
Kidney Cancer Drugs 10
Drug Delivery 9
Needles and Syringes 9
Brain Cancer Drugs 8
Bladder Cancer Drugs 8
Allergy Drugs 8
Hematology 7
Pancreatic Cancer Drugs 7
Dermatological Drugs 7
Liver Cancer Drugs 6
Sexual and Reproductive Health Drugs 6
Therapeutic Area 5
Drugs by Therapeutic Area 5
Hospital Information Systems 5
Gastrointestinal Drugs 5
Urological Disorders Drugs 5
Immunosuppressive Drugs 5
Pharmaceutical Intermediates 4
Healthcare Services 4
Prostate Cancer Drugs 4
Dermatology 4
Vaccines 4
Neurology 3
Diabetes Drugs 3
In Vitro Diagnostics 3
Transdermal and Transmucosal Drug Delivery 3
Medical Devices 3
Thyroid Cancer Drugs 3
Cardiology 3
Alzheimer's Disease Drugs 3
Company Reports 2
Animal Pharmaceuticals 2
Urology and Nephrology 2
Proteomics 2
Infectious Disease Testing 2
Laboratory Testing 2
Biomaterials 2
Cancer Vaccines 2
Uterine Cancer Drugs 2
Nanomedicine 2
Laboratory Equipment 2
Pediatrics 2
HIV/AIDS Drugs 2
Psoriasis Drugs 2
Patient Monitoring Equipment 1
Generic Drugs 1
Pharmacoeconomics 1
Medical Imaging 1
Drug Abuse Screening 1
Analgesics 1
Cough and Cold Drugs 1
Managed Care 1
Radiography 1
Stem Cells 1
Biomarkers 1
Over the Counter (OTC) Drugs 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Vitamins and Dietary Supplements 1
Antibiotics 1
Gastroenterology 1
Endocrinology 1
Maternal and Neonatal Care 1
Asthma Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

695 Results (Page 16 of 35)
- Relevance
  Sort by

Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
1699 Pages
Global

From

€2209EUR$2,500USD£1,934GBP

Influenza Medications Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
January 2022
115 Pages
Global

From

€4198EUR$4,750USD£3,675GBP

Digital Marketing Trends in Hepatocellular Carcinoma

 Report
September 2022
30 Pages
Global

From

€1723EUR$1,950USD£1,509GBP

DNA Repair Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2024
88 Pages
Global

From

€3500EUR$4,243USD£3,171GBP

Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
1814 Pages
Global

From

€1767EUR$2,000USD£1,547GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Biobetters - Global Strategic Business Report

 Report
December 2025
488 Pages
Global

From

€5170EUR$5,850USD£4,526GBP

Non-Small Cell Lung Cancer (NSCLC) Therapeutics - Global Strategic Business Report

 Report
December 2025
271 Pages
Global

From

€5170EUR$5,850USD£4,526GBP

Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
628 Pages
Global

From

€2209EUR$2,500USD£1,934GBP

Royalty Rates in Pharmaceutical and Biotechnology Deals 2010-2025

 Report
September 2025
950 Pages
Global

From

€4414EUR$4,995USD£3,864GBP

Retinal Drugs and Biologics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
93 Pages
Global

From

€3500EUR$4,243USD£3,171GBP

Cervical Cancer Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3968EUR$4,490USD£3,474GBP

HPV Associated Disorders Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3968EUR$4,490USD£3,474GBP

The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups

 Report
October 2022
58 Pages
Global

€9458EUR$11,077USD£8,000GBP

Myelofibrosis Therapeutics - Global Strategic Business Report

 Report
December 2025
136 Pages
Global

From

€5170EUR$5,850USD£4,526GBP

Cervical Cancer - Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€1767EUR$2,000USD£1,547GBP

€2209EUR$2,500USD£1,934GBP

Hemlibra (Emicizumab-kxwh) - Drug Insight and Market Forecast - 2030

 Report
August 2020
80 Pages
Global

From

€1944EUR$2,200USD£1,702GBP

€2430EUR$2,750USD£2,128GBP

Next Generation Drug Conjugates Market: Industry Trends and Global Forecasts, Till 2035

 Report
December 2025
120 Pages
Global

From

€4241EUR$4,799USD£3,713GBP

Antithrombotic Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
89 Pages
Global

From

€3500EUR$4,243USD£3,171GBP

Cancer Biomarkers Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Biomarker, Type of Cancer and Key Geographical Regions

 Report
March 2025
309 Pages
Global

From

€3976EUR$4,499USD£3,481GBP

Bisphosphonate Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

 Report
May 2023
103 Pages
Global

From

€3500EUR$4,243USD£3,171GBP

695 Results (Page 16 of 35)
- 1
- 14
- 15
- 16
- 17
- 18

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.